Bristol-Myers Squibb Co news

   Watch this stock
Showing stories 1 - 10 of about 152   

Articles published

BMY 59.19 +1.50 (2.60%)
price chart
Company Update: Bristol-Myers Squibb Co (NYSE:BMY)
[Business Wire] Bristol-Myers Squibb Co (NYSE:BMY) will announce results for the fourth quarter and full year of 2014 on Tuesday, January 27, 2015.
Market Update: Bristol-Myers Squibb Company (NYSE:BMY) - Bristol-Myers ...  Jutia Group
Morning Market Movers: Bristol-Myers Squibb Company (BMY), Consolidated ...  WallStreet Scope
Related articles »  
Pharma Equities Technical Analysis -- GlaxoSmithKline, Bristol-Myers Squibb ...
Shares of the company traded at a PE ratio of 33.67. Bristol-Myers Squibb Co.'s shares have fallen by 3.33% in the previous three trading sessions, while the stock has gained 12.79% in the last three months and 8.54% on YTD basis.
Related articles »  
Fitch Raises Outlook on Bristol-Myers Squibb (BMY) to Stable; Notes Firm ...
Fitch Ratings has affirmed Bristol-Myers Squibb Co.'s (Bristol- Myers, Bristol) (NYSE: BMY) Issuer Default Rating (IDR) at 'A-' and has revised the Rating Outlook to Stable from Negative.
Fitch Revises Bristol-Myers Squibb's Outlook to Stable; Affirms IDR at ...  Business Wire (press release)
Related articles »  
Bristol-Myers Squibb Co's Hep C Drug Denied; Gilead Sciences Inc. Smiling (for ...
"Best-case scenario, the decision was because the FDA gave Bristol-Myers Squibb (NYSE: BMY ) an indication that the data from clinical trials testing Daklinza combined with Sovaldi -- curing up to 100% of patients in some trials -- will be on Daklinza ...
Related articles »  
Mid-Day Movers: Vanguard Natural Resources, LLC (VNR), Bristol-Myers ...
Bristol-Myers Squibb Company (BMY) of the Healthcare sector (Drug Manufacturers - Major) has gained 1.46% per share at mid-day today.
Related articles »  
Bristol-Myers Squibb Company : Ono Pharmaceutical, Bristol-Myers Squibb and ...
TOKYO & OSAKA, Japan & NEW YORK--(BUSINESS WIRE)--Ono Pharmaceutical Co.,Ltd. (Tokyo: 4528), Bristol-Myers Squibb Company(NYSE:BMY) and Kyowa Hakko Kirin Co., Ltd. (Tokyo: 4151,"Kyowa Hakko Kirin") announced today the companies have ...
Related articles »  
Bristol-Myers Squibb, Merck & Co Drugs Show Promise In Early Trials For ...
Bristol-Myers Squibb Co (NYSE:BMY) and Merck & Co., Inc.'s (NYSE:MRK) respective cancer immunotherapies, Opdivo and Keytruda, showed promising results for the treatment of Hodgkin's lymphoma in two separate studies, researchers announced ...
Bristol-Myers Squibb partners Merck & Co for Hodgkin Therapy  The Westside Story
Bristol-Myers, Merck Drugs Give Hope in Hodgkin's Trials  Bloomberg
Related articles »  
Form 4 BRISTOL MYERS SQUIBB CO For: Dec 05 Filed by: ANDREOTTI ...
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). 1. Name and Address of Reporting Person *. ANDREOTTI LAMBERTO. (Last), (First), (Middle). BRISTOL-MYERS SQUIBB COMPANY.
Related articles »  
Bristol-Myers Squibb to Announce Results for Fourth Quarter, Full Year 2014 on ...
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the fourth quarter and full year of 2014 on Tuesday, January 27, 2015.
Gilead Sciences, Inc. (GILD), Biogen Idec Inc (BIIB), Bristol-Myers Squibb Co ...
The SEC 13F filings of Orbimed Advisors LLC for the period ended September 30, 2014, showed that its top three holdings are Gilead Sciences, Inc. (NASDAQ:GILD), Biogen Idec Inc (NASDAQ:BIIB), and Bristol-Myers Squibb Co (NYSE:BMY). The filings ...
Bristol-Myers Squibb Hits New 12-Month High at $59.50 (BMY)  Mideast Time
Watch List: Philip Morris International, Inc. (PM), Bristol-Myers Squibb ...  WallStreet Scope
Related articles »